HDAC3 and neoplasm: Interestingly, we found that entinostat (target of HDAC1/HDAC3) acts as a tumor suppressor and a pro-apoptosis and cell cycle-blocking drug and acts on HCCLM3 and Huh-7 (concentrations of 0, 5, and 10 μM).